Xuefeng Leng

8PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursBehavioural epidemiologyEpidemiological methodsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 22, 2025
Real-world efficacy of PD-1 inhibitors in treating oesophageal squamous cell carcinoma (ESCAPE): protocol of a multicentre, real-world, observational, cohort study.

Chenghao Wang, Qin Xie, Yan Miao

|Jun 04, 2025
Neoadjuvant chemotherapy or chemoradiotherapy plus sintilimab versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a study protocol of a multicentre, randomised, controlled, phase III trial (SCIENCE study).

Wenwu He, Hansong Bai, Jiahua Lv

|Jan 27, 2025
Giant thymolipoma in a 16-year-old girl with multimodal diagnostic approach and surgical management: a case report.

Ziwei Wang, Jicheng Xiong, Lin Peng

|Sep 04, 2024
Treatment Paradigm for Cervical Esophageal Cancer: Now and Then.

Simiao Lu, Yongtao Han, Xuefeng Leng

|Aug 29, 2024
Long-term outcomes of smoker and drinker with oesophageal squamous cell carcinoma after oesophagectomy: a large-scale propensity score matching analysis.

Kexun Li, Simiao Lu, Changding Li

|Jun 04, 2024
Enhanced Recovery Protocol Versus Conventional Care in Patients Undergoing Esophagectomy for Cancer: Advantages in Clinical and Patient-Reported Outcomes.

Yixuan Huang, Qin Xie, Xing Wei

Pageof 2

Frequent Collaborators

2 joint publications

Wenwu He

2 joint publications

Qiuling Shi

1 joint publications

Hong Wu

1 joint publications

Qianshi Liu